Cambridge Technologies Revenue and Competitors

Cambridge Technologies is an independent owner-operated custom vaccine company working with veterinarians and livestock producers to provide solutions to animal health problems. We use cutting-edge molecular diagnostic and manufacturing techniques to manage the entire custom vaccine process and to provide you with the best possible solutions for managing emerging health problems. Diagnostic and research scientists work under the guidance of Dr. Ben Hause at a modern laboratory specializing in personalized service. Techniques including metagenomics, genetic sequencing, qPCR, culture, sensitivity and serology will be employed as needed to precisely determine the right isolates needed for vaccine production. Research scientists alongside the diagnosticians keep Cambridge on the cutting-edge of isolate identification and characterization. Cambridge Technologies vaccines are formulated and produced at our USDA-licensed 37,000-square-foot manufacturing facility featuring a state-of-the-art fermentation suite. The vaccine production team has extensive experience in diagnostics, R&D, quality control, regulatory affairs, and both commercial and custom vaccine production. Vaccines from Cambridge Technologies are truly customized to the customer’s needs, including a range of adjuvant choices, label options, and SoliDose implant delivery in bovine products.